Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Anheuser-Busch InBev

Medtronic

Philip Morris

A Lower-risk portfolio can be created by buying durable companies with long track records of rewarding shareholders at attractively low prices. Overpaying for a stock can lead to outsized risks, so it's important to separate price from value and company from stock. Medtronic and Altria are dividend aristocrat value stocks trading far below historical norms, offering income and potential for capital gains.

I'm Buying Dividend Aristocrats With Up To 8.5% Yield

AT&T

Vale S.A.

In the last ten years, the S&P 500 index has delivered annualized price return of 10.8%. For the same period, the total returns (including dividend gains) have been at an annual rate of 12.87%.

3 Undervalued Blue-Chip Stocks to Buy at a P/E of Less than 10

Black Hills

Federal Realty Investment Trust

Northwest Natural Gas

Universal Corp

24/7 Insights Dependable passive income supplements Social Security and pension income.

6 Dividend Kings That Offer Investors a Passive Income Home Run

Altria's stock advanced strongly in the first half of 2024, gaining nearly 13% in just six months. The stock's massive 8.5% dividend yield remains the biggest attraction.

High-Yield Altria Stock Rose With the Market in the First Half of 2024, but Don't Get Too Excited for the Rest of the Year

Altria has an impressively long and consistent dividend growth record. Altria's stock price has been stagnant, but the company offers a high dividend yield for investors getting in at these levels. The company's dividend growth has been consistent but low for the last couple of years with the coming August hike likely to end up at 4%, as usual.

Altria Pays You Handsomely To Wait For Future Growth

Diamondback Energy

The S&P 500 is booming. The popular benchmark index is up 16% this year and is 44% higher since the start of 2023.

3 Stocks to Buy if the S&P 500 Retraces Its Gains to October Lows

Ares Capital

British American Tobacco

Blackstone Secured Lending Fund

Imperial Brands PLC

Blue Owl Capital Corp

SPDR S&P 500 ETF Trust

The S&P 500 currently yields just 1.2%, a level that may not be suitable for most income investors. In this article, I present 2 higher yielding stocks that are either reasonably valued or undervalued. Both carry strong balance sheets, pay well-covered dividends, and have plenty of capacity for growth.

I'm Locking 7-10% Yields In This Upside-Down Market

Altria: 3 Things You Need To Know About This 9% Yielding Dividend Aristocrat

Realty Income Corp

Verizon

High-yield dividend stocks for a recession can be an excellent way for investors to continue generating income even during economic downturns. The key is to use dividend reinvestment plans, or DRIPs, which automatically channel dividend payments back into purchasing additional shares.

Drip Your Way to Wealth: 3 High-Yield Dividend Stock Picks for a Recession

Federal regulators authorized the marketing of four of Altria's menthol-flavored e-vapor products. Altria stock is a solid defensive holding for value seekers and income investors.

Altria Investors Just Got Some Bullish News

Altria Group and British American Tobacco can protect your portfolio during a market downturn. Both stocks can also deliver huge dividend yields.

Best Stock to Buy Right Now: Altria Group vs. British American Tobacco

Identifying potential risks in your portfolio is crucial for long-term success. As of July 2024, several stocks exhibit significant warning signs suggesting they might be stocks to sell now.

3 Ticking Time Bombs in Your Portfolio to Sell Now

Altria and AT&T have both been on a tear during the first six months of 2024. Meanwhile, the S&P 500 has crossed over into premium valuation territory, buoyed by Nvidia's incredible run.

Can These 2 Ultra-High-Yield Dividend Stocks Outperform the S&P 500 in 2024?

Crown Castle International

Chevron

Pfizer

Today, we will discuss juicy long-term dividend growth stocks that have grown for over a decade. It's fairly easy to find stocks that have continuously grown dividends over the past decade.

7 Juicy Dividend Stocks That Have Grown for More Than a Decade

Lockheed Martin

Merck

Newmont Mining

Rio Tinto plc Sponsored

Starbucks

An investor is unlikely to beat inflation by simply holding funds in a bank account. In such a scenario, there will be continued loss of purchasing power due to inflation increasing faster than average interest rates.

Beat the CPI: 7 Blue-Chip Stocks Growing Faster Than Inflation

Disney

Altria is an attractively valued defensive stock that pays a huge dividend. Disney's competitive strengths make it a smart comeback play.

A Bull Market Is Here: 2 Brilliant Stocks Down 41% and 51% to Buy Right Now

Altria (MO) is benefiting from its focus on expanding smoke-free alternatives and strong pricing power amid low cigarette volumes.

Altria (MO) Up 11% in 3 Months: Is There More Room for Growth?

Altria Group stock has lagged the market in recent years. However, several factors point to a bright future.

Where Will Altria Stock Be in 5 Years?

Bristol-Myers

Comcast

Campbell Soup

Dow Inc

Duke Energy

Gilead Sciences

Johnson & Johnson

Kinder Morgan

Polaris

PNC Financial Services

Sempra Energy

Toronto-Dominion Bank

U.S. Bancorp

Morningstar published 10 Best Value Stocks to Buy for the Long Term, undervalued blue-chip stocks with low price to fair value. Valuation and future return of each stock analyzed, compared to the S&P 500, Bristol-Myers has the highest potential rate of return. In comparison to Morningstar's 10 Best Value Stocks with 10 Best Dividend Stocks, Bristol-Myers stands out as undervalued with a high potential return.

Going Beyond Morningstar's 10 Best Value Stocks List

Volkswagen AG

The stocks of iconic brands are en masse. However, the informational asymmetry linked to the financial markets means that few are undervalued.

3 Iconic Brands Offering Both 5% Yields and 50% Upside at Current P/Es

Clorox

Nine long-term dividend growth companies announced their annual dividend increases in June. Investors in convenience store chain Casey's, grocer Kroger's, and health insurer UnitedHealth were rewarded with 10%+ income boosts. July brings increases from another 17 long-term dividend growth companies including Clorox, Altria, and Duke Energy.

Clorox, Altria Among 17 Companies To Announce Annual Dividend Increases In July

The FDA recently authorized the sale of four menthol-flavored NJOY products from Altria. NJOY could help the company return to revenue growth.

Can NJOY Help Propel Altria Group Stock Higher?

24/7 Insights Passive income is one of the best ways to supplement Social Security or pension income.

5 Highest Yielding S&P 500 Passive Income Stocks All Pay More Than Treasury Bonds

Automatic Data Processing

C.H. Robinson Worldwide

Enterprise Products Partners

National Fuel Gas

Novartis

PPG Industries

Tompkins Financial

The market remains near record highs with the best-ever presidential election year return and 13th-best S&P return through the first half of the year. Free cash flow yield is the best valuation metric since 1990, averaging 17.6% annual returns for the most undervalued companies over the last 33 years. Screening for high free cash flow yield dividend aristocrats can provide a diversified portfolio of quality, income dependability, growth, and value.

9 High-Yield Dividend Aristocrat Bargain Buys

News for Altria Stock (MO)